152 related articles for article (PubMed ID: 11056123)
1. Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome.
de Leo V; la Marca A; Morgante G; Ciotta L; Mencaglia L; Cianci A; Petraglia F
Hum Reprod; 2000 Nov; 15(11):2302-5. PubMed ID: 11056123
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
Rouzi AA; Ardawi MS
Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
[TBL] [Abstract][Full Text] [Related]
3. Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy.
Shobokshi A; Shaarawy M
J Soc Gynecol Investig; 2003 Feb; 10(2):99-104. PubMed ID: 12593999
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease.
Tiitinen AE; Laatikainen TJ; Seppälä MT
Fertil Steril; 1993 Jul; 60(1):58-62. PubMed ID: 7685718
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome.
Homburg R; Orvieto R; Bar-Hava I; Ben-Rafael Z
Hum Reprod; 1996 Apr; 11(4):716-9. PubMed ID: 8671313
[TBL] [Abstract][Full Text] [Related]
6. Decline in insulin-like growth factor I levels after clomiphene citrate does not correct hyperandrogenemia in polycystic ovary syndrome.
Fiad TM; Smith TP; Cunningham SK; McKenna TJ
J Clin Endocrinol Metab; 1998 Jul; 83(7):2394-8. PubMed ID: 9661617
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome.
Mohsen IA
Gynecol Endocrinol; 2012 Apr; 28(4):269-72. PubMed ID: 21970545
[TBL] [Abstract][Full Text] [Related]
8. Octreotide is not useful for clomiphene citrate resistance in patients with polycystic ovary syndrome but may reduce the likelihood of ovarian hyperstimulation syndrome.
Morris RS; Karande VC; Dudkiewicz A; Morris JL; Gleicher N
Fertil Steril; 1999 Mar; 71(3):452-6. PubMed ID: 10065781
[TBL] [Abstract][Full Text] [Related]
9. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
Zaidi J; Jacobs H; Campbell S; Tan SL
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
[TBL] [Abstract][Full Text] [Related]
10. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
Imani B; Eijkemans MJ; de Jong FH; Payne NN; Bouchard P; Giudice LC; Fauser BC
J Clin Endocrinol Metab; 2000 Feb; 85(2):676-82. PubMed ID: 10690875
[TBL] [Abstract][Full Text] [Related]
11. Effect of metformin on insulin-like growth factor (IGF) I and IGF-binding protein I in polycystic ovary syndrome.
De Leo V; La Marca A; Orvieto R; Morgante G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1598-600. PubMed ID: 10770203
[TBL] [Abstract][Full Text] [Related]
12. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors.
Stadtmauer LA; Toma SK; Riehl RM; Talbert LM
Fertil Steril; 2001 Mar; 75(3):505-9. PubMed ID: 11239532
[TBL] [Abstract][Full Text] [Related]
13. Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial.
Yarali H; Yildiz BO; Demirol A; Zeyneloğlu HB; Yiğit N; Bükülmez O; Koray Z
Hum Reprod; 2002 Feb; 17(2):289-94. PubMed ID: 11821265
[TBL] [Abstract][Full Text] [Related]
14. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
Pawelczyk L; Spaczynski RZ; Banaszewska B; Duleba AJ
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):209-13. PubMed ID: 15063962
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment and co-administration of oral anti-diabetic agent with clomiphene citrate or rFSH for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome.
Begum MR; Akhter S; Ehsan M; Begum MS; Khan F
J Obstet Gynaecol Res; 2013 May; 39(5):966-73. PubMed ID: 23379651
[TBL] [Abstract][Full Text] [Related]
16. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy.
Berker B; Emral R; Demirel C; Corapcioglu D; Unlu C; Kose K
Gynecol Endocrinol; 2004 Sep; 19(3):125-33. PubMed ID: 15697073
[TBL] [Abstract][Full Text] [Related]
17. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
Khorram O; Helliwell JP; Katz S; Bonpane CM; Jaramillo L
Fertil Steril; 2006 May; 85(5):1448-51. PubMed ID: 16579997
[TBL] [Abstract][Full Text] [Related]
18. The relationship between insulin sensitivity and insulin-like growth factor-binding protein-1.
Morris DV; Falcone T
Gynecol Endocrinol; 1996 Dec; 10(6):407-12. PubMed ID: 9032568
[TBL] [Abstract][Full Text] [Related]
19. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome.
Jakubowicz DJ; Seppälä M; Jakubowicz S; Rodriguez-Armas O; Rivas-Santiago A; Koistinen H; Koistinen R; Nestler JE
J Clin Endocrinol Metab; 2001 Mar; 86(3):1126-33. PubMed ID: 11238496
[TBL] [Abstract][Full Text] [Related]
20. Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial.
George SS; George K; Irwin C; Job V; Selvakumar R; Jeyaseelan V; Seshadri MS
Hum Reprod; 2003 Feb; 18(2):299-304. PubMed ID: 12571165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
